Research on therapeutic cancer vaccines is ongoing, with advancements and challenges being reported. Various studies and reviews are exploring the prospects and development of these vaccines for different types of cancer, including breast, prostate, and colorectal cancer. The field is seeing breakthroughs, such as the use of mRNA vaccines, but also faces obstacles, including T cell exhaustion and the need for personalized approaches.